Interstitial Lung Disease in Systemic Sclerosis: Focus on Early Detection and Intervention
Aryeh Fischer,1 Nina M Patel,2 Elizabeth R Volkmann3 1Division of Rheumatology, Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado School of Medicine, Denver, CO, USA; 2Division of Pulmonary, Allergy and Critical Care Medicine, Columbia Universi...
Guardado en:
Autores principales: | Fischer A, Patel NM, Volkmann ER |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2c548f2fa33040cb9dc89b82735b64d3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Current Perspectives On Emerging Biomarkers For Rheumatoid Arthritis-Associated Interstitial Lung Disease
por: Amigues I, et al.
Publicado: (2019) -
Progressive fibrosing interstitial lung disease: prevalence and clinical outcome
por: Byoung Soo Kwon, et al.
Publicado: (2021) -
Rheumatoid arthritis-associated interstitial lung disease
por: Brown KK, et al.
Publicado: (2012) -
Animal models of systemic sclerosis: their utility and limitations
por: Artlett CM
Publicado: (2014) -
The role of TGF-β or BMPR2 signaling pathway-related miRNA in pulmonary arterial hypertension and systemic sclerosis
por: Bei Xu, et al.
Publicado: (2021)